Physician profile
Oday Obaid
NPI 1891271193
$2,878.36
in general payments reported to CMS, 2019-2025
12 companies · $745 in 2025
The $745 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $702 · 2023: $616 · 2024: $815 · 2025: $745.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Travel and Lodging: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.95 |
| Travel and Lodging | $370.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $827.52 | 2022-2023 | Gore Bio-A Tissue Reinforcement |
| Davol INC. | $433.18 | 2022-2024 | Arista Ah Flexitip |
| Axogen | $411.70 | 2023-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Connector |
| Polynovo North America LLC | $286.85 | 2024 | Novosorb Btm |
| Merz North America, INC. | $171.14 | 2022 | |
| Integra Lifesciences Corporation | $158.47 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $154.05 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Becton, Dickinson and Company | $131.65 | 2024 | Phasix Mesh |
| Acera Surgical, INC. | $125.27 | 2024 | Restrata Wound Matrix |
| Stryker Corporation | $97.17 | 2025 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Lightbody Medical Technologies INC | $56.10 | 2025 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oday Obaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.